This document confirms the announcement of a £50m per annum central budget for specialist palliative care from 2003-04 and sets out the purposes for which it is to be used.
2. Background
The NHS Cancer Plan promised that NHS investment in specialist palliative care would increase by £50m by 2003-04, compared with 2000-01. The increase would be used to tackle inequalities in access to specialist palliative care and to enable the NHS to make a more realistic contribution to the costs of hospices in providing agreed levels of service.
3. Progress towards the £50m commitment has been slow. In July Ministers asked Mike Richards, the National Cancer Director, to bring together a National Partnership Group drawn from the NHS and the voluntary sector (see Annex A for full membership). The Group was asked to develop proposals for a new approach to specialist palliative care planning and funding that would ensure delivery of the £50m commitment and develop a mechanism for long term investment that would command confidence.
4. In November 2002, an in-year non-recurrent allocation of £10m was made, to enable faster progress towards the £50m per annum commitment.
5. On 30 December 2002, Hazel Blears, Parliamentary Under Secretary for Public Health, announced the creation of a new £50m per annum central budget for specialist palliative care. The text of the press release is on the Department's press release database. This will run for the period 2003-04 to 2005-06, with the intention that it will be built into PCT allocations in due course. It is expected that, over time, local health communities will supplement this budget from their own allocations.
6. The £50m p.a. is additional to the increases in specialist palliative care spending that the NHS has already made in 2001-02 and 2002-03. And it will enable the NHS to pick up the recurrent costs of the additional £10m allocated in November. It will mean that the NHS can more than meet the NHS Cancer Plan commitment.
7. Its purpose is to tackle inequalities in access to specialist palliative care and enable a more realistic contribution to the agreed costs of hospices, in line with the NHS Cancer Plan. For this purpose, specialist palliative care includes inpatient beds (including those provided by hospices), home care teams, hospital support teams, Marie Curie (or equivalent) nursing services, outpatient services, and day care, bereavement services, and education for staff beyond the specialist teams.
8. The £50m per annum is a revenue budget, but virement to capital is permitted in line with the usual virement arrangements.
9. Annex B sets out shares of the £50m per annum budget by PCT, and aggregated at StHA level (recognising that palliative care will need to be planned and funded for populations larger than an individual PCT).
10. The arrangements for accessing and deploying the budget build on the requirements set out in the Planning and Priorities Framework and Local Delivery Plan (LDP) guidance (www.doh.gov.uk/ldp2003-2006) but include additional elements designed to ensure that all the stakeholders, including voluntary sector partners locally and nationally, have confidence in the arrangements. This includes an important role for the National Partnership Group.
11. The core requirements are:
12. The Partnership Group's involvement is designed to ensure a transparent process, enabling all partners locally and nationally to have confidence that the £50m commitment will be met in full, that the funding will be committed for its intended purpose, and that the funding increase will yield the maximum benefit for patients. The aim is to foster stronger partnership working at all levels.
13. The Partnership Group will want to satisfy itself that the specialist palliative care plans meet the PPF and LDP requirements, and follow the aims and principles that the Group has developed (attached at Annex C). The Group recognises that time is tight and detailed work will continue beyond March. However, in its March assessment of the plans, the Group will want to be satisfied that
14. Progress will be monitored through the arrangements for LDPs overall, and the National Partnership Group will be kept informed of progress. In addition, it will be important that cancer networks keep all their local stakeholders informed of progress. Over time, we envisage a diminishing role for the National Partnership Group, with growing reliance on the local partnership arrangements.
15. The National Partnership Group will explore what supporting material can be made available to assist networks with their planning.
Further information can be obtained from:
Sue Hawkett (020 7972 4836) sue.hawkett@doh.gsi.gov.uk
Robert Freeman (092 7972 3958) robert.freeman@doh.gsi.gov.uk